Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. | Chief Financial Officer | Common Stock | 182K | $70.8K | $0.39 | Mar 2, 2023 | Direct |
C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32.5K | Jun 20, 2024 | Direct | ||
Flexion Therapeutics Inc | Director | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CCCC | C4 Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
CCCC | C4 Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
ATRA | Atara Biotherapeutics, Inc. | Mar 2, 2023 | 1 | -$24.9K | 4 | Mar 6, 2023 | Chief Financial Officer |
CCCC | C4 Therapeutics, Inc. | Feb 8, 2023 | 1 | $31.7K | 4 | Feb 10, 2023 | Director |
ATRA | Atara Biotherapeutics, Inc. | Feb 7, 2023 | 1 | -$13.6K | 4 | Feb 9, 2023 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | Nov 16, 2022 | 2 | -$28.1K | 4 | Nov 18, 2022 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | Aug 16, 2022 | 1 | -$29.9K | 4 | Aug 18, 2022 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | Jun 8, 2022 | 1 | -$33K | 4 | Jun 10, 2022 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | May 17, 2022 | 2 | -$29.7K | 4 | May 19, 2022 | Chief Financial Officer |
CCCC | C4 Therapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 17, 2022 | Director |
CCCC | C4 Therapeutics, Inc. | Mar 16, 2022 | 0 | $0 | 3 | Mar 17, 2022 | Director |
ATRA | Atara Biotherapeutics, Inc. | Mar 1, 2022 | 4 | -$37.1K | 4 | Mar 3, 2022 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | Feb 7, 2022 | 1 | -$36.1K | 4 | Feb 9, 2022 | Chief Financial Officer |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
ATRA | Atara Biotherapeutics, Inc. | Nov 16, 2021 | 1 | -$62.6K | 4 | Nov 18, 2021 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | Aug 17, 2021 | 1 | -$44.9K | 4 | Aug 19, 2021 | Chief Financial Officer |
FLXN | Flexion Therapeutics Inc | Jul 9, 2021 | 1 | $0 | 4 | Jul 12, 2021 | Director |
FLXN | Flexion Therapeutics Inc | Jul 9, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 8, 2021 | 1 | -$81.8K | 4 | Jun 9, 2021 | Chief Financial Officer |
ATRA | Atara Biotherapeutics, Inc. | May 18, 2021 | 1 | -$52.6K | 4 | May 20, 2021 | Chief Financial Officer |